慢性胰腺炎课件_2

上传人:仙*** 文档编号:243973672 上传时间:2024-10-01 格式:PPT 页数:41 大小:1.01MB
返回 下载 相关 举报
慢性胰腺炎课件_2_第1页
第1页 / 共41页
慢性胰腺炎课件_2_第2页
第2页 / 共41页
慢性胰腺炎课件_2_第3页
第3页 / 共41页
点击查看更多>>
资源描述
Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,.,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,*,1,CHRONIC PANCREATITIS,.,1CHRONIC PANCREATITIS.,2,A 49-year-old man was admitted with a nine-month history of intermittent attacks of epigastric pain, jaundice and fever.,These attacks usually last up to several days associated with nausea and vomiting.,He was well in between attacks and had no loss of weight,2A 49-year-old man was admitte,3,What is your next step?,.,3What is your next step?.,4,Lab Results,AP =1017,GGT= 269,AST =103,ALT =186,TB =2 (DB= 1.1),Alb= 3.2,Lipase =33 (up to 244 during attacks),Amylase= 44,Hb =12,WBC= 5.7,Plts= 223Na =141,K =4.2,Ur =15,Cr =0.9,Ca =8.9,FBS:178,4Lab ResultsAP =1017Hb =12,5,What are arrows?,5What are arrows?,6,Pancreatic calcification,.,6Pancreatic calcification.,7,Transabdominal US,:,No gallstones or mass in head of pancreas,CT scan,: The extrahepatic bile duct was mildly dilated and generous pancreas was noted but there was no mass.,7Transabdominal US: No gallsto,8,Endoscopic Ultrasound,Diffuse hypoechoic enlargement of pancreas. Fine needle aspirate of the pancreas was negative for tumor.,8Endoscopic UltrasoundDiffuse,9,ERCP,There was a long segment of extrahepatic biliary stricture. The pancreatic duct was normal in size but irregular. Brushings, biopsies and bile aspirate were negative for tumor,9ERCPThere was a long segment,10,10,11,The patient underwent,Whipples,operation Histology of the pancreas showed,chronic pancreatitis, no malignancy,.,11The patient underwent Whipp,12,Two presentation:,Episodes of acute inflammation in a previously injured pancreas,Chronic damage with persistent pain or malabsorption,Etiology :,same as acute pancreatitis “pancreatitis associated with gallstones predaminantly acute or relapsing-acute”,More idiopathic types,12Two presentation:,13,Most common cause :,In adults: alcohol intake,In children: cystic fibrosis,Idiopathic chronic pancreatitis is the leading cause of nonalcoholic chronic pancreatitis,13Most common cause :,14,PATHOPHYSIOLOGY,The events that initiate an inflamatory process are still not well understood,In the alcohol-induced : suggested that the primary defect may be the precipitation of protein(inspissated enzyme ),In fact ,shown that alcohol has direct toxic effect on the pancreas,14PATHOPHYSIOLOGYThe events th,15,Clinical features,abdominal pain:,may be continuous, intermittent or absent,Pattern is often atypical,RUQ or LUQ of the back,Diffuse throughout upper abdomen,May be referred to the anterior chest or flank,Typical form:,Persistent , deep-seated,Unresponsive to antacids,Worsened by alcohol intake or a heavy meal (especially fatty foods),Often need narcotics,15Clinical featuresabdominal p,16,Pancreatic insufficiency,Weight loss,Fat malabsorption:,Steatorrhea: 15% of patients present with steatorrhea and no pain,Pancreatic diabetes:,Like DM1 needs insulin , but risk of hypoglycemia is more than it (because alfa cells is also affected,Fat-soluble vitamin deficiency,rare,16Pancreatic insufficiency,17,Lab data,Amylase and lipase : usually normal,CBC ,electrolytes, and liver function tests are typically normal,Bilrubin and ALP may be increased,Impaired glucose intolerance and elevated fasting blood glucose,Sudan staining of feces or quantitative test for steatorrhea,fecal elastase,(Among pancreatic function tests, fecal elastase measurement is the most sensitive and specific, especially in the early phases of pancreatic insufficiency),17Lab dataAmylase and lipase :,18,Cont,Classic triad “,pancreatic calcification , steatorrhea , and diabetes mellitus,“usually establishes chronic pancreatitis,Classic triad : found in fewer than one-third,It is often necessary to perform,secretin stimulation test,(abnormal when 60% or more of pancreatic exocrine function has been lost),A decreased,serum trypsinogen (20ng/ml) or a fecal elastase level of 100ug/mg,of stool strongly suggests severe pancreatic insufficiency,18Cont,Classic triad “ pancrea,19,Imaging studies,Plain films,:,Pancreatic calcifications :,% 30,most common with,alcoholic pancreatitis, but is also seen in the hereditary and tropical forms of the disorder; it is rare in idiopathic pancreatitis.,19Imaging studies Plain films,20,20,21,21,22,CT, MRI, US,calcifications,ductal dilatation,enlargement of the pancreas,fluid collections (eg, pseudocysts),22 CT, MRI, US calcification,23,23,24,24,25,ERCP,Choice when calcifications are not present and there is no evidence of steatorrhea.,a normal study should not rule out the diagnosis of chronic pancreatitis,25ERCP Choice when calcificati,26,ERCP,May provide useful information on the status of the pancreatic ductal system,Abnormalities include :,1)luminal narowing,2)irregularitis in the ductal system with stenosis, dilation,saculation,and ectasia,3)blockage of the duct by calcium deposits,.,26ERCPMay provide useful infor,27,27,28,Endoscopic ultrasonography,The most predictive endosonographic feature is the presence of stone,Other suggestive features include:,visible side branches,cysts,lobularity,irregular main pancreatic duct,hyperechoic foci and strands,dilation of the main pancreatic duct,hyperechoic margins of the main pancreatic duct.,28Endoscopic ultrasonographyTh,29,29,30,Complications,pseudocyst formation,bile duct or duodenal obstruction,pancreatic ascites or pleural effusion,splenic vein thrombosis,Pseudoaneurysms,pancreatic cancer,acute attacks of pancreatitis( particularly alcoholics who continue drinking),30Complicationspseudocyst form,31,DIFFERENTIAL DIAGNOSIS,Pancreatic cancer (most important),older age,absence of a history of alcohol use,weight loss,a protracted flare of symptoms,onset of significant constitutional symptoms,pancreatic duct stricture greater than 10 mm in length on ERCP,Markers such as CA 19-9 and CEA,peptic ulcer disease,gallstones,irritable bowel syndrome,Acute pancreatitis,31DIFFERENTIAL DIAGNOSISPancre,32,TREATMENT,.,32TREATMENT.,33,PAIN MANAGEMENT,stepwise approach :,general recommendations,pancreatic enzyme supplementation,Analgesics,invasive options,33PAIN MANAGEMENTstepwise appr,34,General recommendations,Establish a secure diagnosis,Cessation of alcohol intake,Small meals,34General recommendationsEstab,35,Pancreatic enzyme supplements,not very effective,response may be better in young women with small duct disease.,MECHANISM:,suppression of feedback loops in the duodenum that regulate the release of cholecystokinin (CCK), the hormone that stimulates digestive enzyme secretion from the exocrine pancreas,six tablets of,Viokase,which contains:,16,000 units of lipase,30,000 units of protease,30,000 units of amylase.,35Pancreatic enzyme supplement,36,Patients should also be treated with acid suppression (either with an H2 receptor blocker or a proton pump inhibitor) to reduce inactivation of the enzymes from gastric acid.,36Patients should also be trea,37,Analgesics,if pancreatic enzyme therapy fails to control pain.,short course of narcotics coupled with low dose amitriptyline and a nonsteroidal antiinflammatory,Simultaneous short-term hospitalization, with the patient kept NPO to minimize pancreatic stimulation, may also be of benefit in breaking the pain cycle.,Chronic narcotic analgesia may be required in patients with persistent significant pain. Long-acting agents such as MS Contin or Fentanyl patches are generally more effective than short acting medications, which last only three or four hours.,37Analgesicsif pancreatic enzy,38,Other medical therapies,octreotide,:cannot be recommended for general use.,Antioxidant therapy,:vitamin C, E, methionine and selenium,38Other medical therapiesoctre,39,Specialized approaches,Celiac nerve blocks,Endoscopic stenting of the pancreatic duct or pancreatic sphincterotomy,Extracorporeal shock wave lithotripsy,Surgery,39Specialized approachesCeliac,40,Maldigestion management,Pancreatic enzymes:,Steatorrhea could be abolished if 10% of the normal amount of lipase could be delivered to the duodenum at the proper time,Poor therapeutic results because of :,Lipase is inactivated by gastric acid,Food empties from the stomach faster than do the pancreatic enzymes,Batches of commercially available pancreatic extracts vary in enzyme activity,40Maldigestion managementPancr,41,Adjuants:,H2 blockers,Sodium bicarbonate,PPIs,41Adjuants:,
展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 管理文书 > 施工组织


copyright@ 2023-2025  zhuangpeitu.com 装配图网版权所有   联系电话:18123376007

备案号:ICP2024067431-1 川公网安备51140202000466号


本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!